Pulmonary opacity unresponsive to anti-infective therapy: Clinical insights from a case ultimately diagnosed as lung adenocarcinoma
DOI:
https://doi.org/10.12669/pjms.42.11.16549Keywords:
Pneumonic-type lung carcinoma (PTLC); Lung adenocarcinoma; Anti-infective therapy; Pulmonary opacityAbstract
Lung cancer ranks as the second most commonly diagnosed malignancy worldwide and remains the leading cause of cancer-related mortality. This case report is of a 77-year-old male smoker presented with a three-month history of cough and white sputum, unresponsive to multiple antibiotic regimens. Chest computed tomography showed bilateral interstitial changes and right upper lobe consolidation initially interpreted as pneumonia. Despite sequential anti-infective therapy with cefoperazone/sulbactam, levofloxacin, meropenem and caspofungin, radiological findings worsened. Next-generation sequencing of bronchial aspirates detected Stenotrophomonas maltophilia, Burkholderia cepacia and Candida albicans, but targeted antimicrobials provided only transient symptom relief. One month after discharge, recurrent cough prompted transbronchial cryobiopsy, which confirmed adenocarcinoma (CK7+, TTF-1+, p40−, Ki-67 ~10%). This case illustrates that pneumonic-type lung adenocarcinoma can mimic refractory pneumonia. When pulmonary opacities fail to respond to adequate anti-infective therapy, especially in elderly patients with chronic productive cough and mildly elevated tumor markers, early histopathological evaluation is essential to avoid diagnostic delay.





